Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas

Table 1 Chemotherapy and anti-EGFR monoclonal antibody (Mab) treatment

Chemotherapy	P67.5		P70		Total
	anti-EGFR Mab treatment		anti-EGFR Mab treatment
	+	-	+	-
None	3	11	20	19	53
ICT	2	2	0	4	8
CCRT	1	6	20	23	50
ACT	0	0	18	11	29
ICT + CCRT	29	32	0	8	69
CCRT + ACT	4	7	2	20	33
ICT + CCRT + ACT	13	36	0	0	49
ICT + ACT	2	0	3	0	5
Total	54	94	63	85	296

Abbreviation: ICT induction chemotherapy, CCRT concurrent chemoradiotherapy, ACT adjuvant chemotherapy

ISSN: 1471-2407